Target identification, validation and characterization for early stages of drug discovery. Identifying drug target via genetic association, expression profiling.
Assays that predict passive absorption of orally administered drugs have become increasingly important in the drug discovery process. As previously described by Faller and Kansy such assays provide rapid, low cost and automation friendly methods to measure a compound’s passive permeability.